STAAR Surgical designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. Co.'s products are implantable Collamer lenses (ICLs) used in refractive surgery and intraocular lenses (IOLs) used in cataract surgery. ICLs, consisting of Co.'s ICL family of products, including the Toric implantable Collamer lenses and EVO+ Visian ICL, are intraocular lenses used to correct refractive conditions such as myopia, hyperopia, astigmatism, and presbyopia. IOLs are prosthetic intraocular lenses used to restore vision that has been affected by cataracts, and include Co.'s lines of silicone IOLs and the Preloaded Injector. The STAA stock yearly return is shown above.
The yearly return on the STAA stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the STAA annual return calculation with any dividends reinvested as applicable (on ex-dates).
|